Botulinski toksin (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Botulinski toksin" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

21nih.gov

4^th place

3^rd place

12doi.org

2^nd place

3web.archive.org

1^st place

2archive.org

6^th place

5^th place

2worldcat.org

5^th place

25^th place

1ama-assn.org

3,257^th place

1,213^th place

1jstor.org

26^th place

86^th place

1plasticsurgery.org

low place

1mef.hr

low place

1,027^th place

1uni-duesseldorf.de

5,334^th place

7,193^rd place

1neurologyindia.com

low place

9,845^th place

1neurology.org

9,919^th place

7,561^st place

1fda.gov

447^th place

642^nd place

1nationalledger.com

6,677^th place

5,093^rd place

1bcm.edu

low place

4,567^th place

1emedicinehealth.com

8,799^th place

1,974^th place

1botoxguide.org

low place

ama-assn.org

jama.ama-assn.org

(en) Arnon, Stephen S.; Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K; Working Group on Civilian Biodefense. (2001-02-21). „Botulinum Toxin as a Biological Weapon: Medical and Public Health Management” (PDF, 0.5 MB). Journal of the American Medical Association 285 (8): 1059–1070. DOI:10.1001/jama.285.8.1059. PMID 11209178.

archive.org

Schiavo, G., Santucci, A., DasGupta, B.R., Mehta, P.P., Jontes, J., Benfenati, F., Wilson, M.C. and Montecucco, C. (1993). „Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds”. FEBS Lett. 335: 99-103. PMID 8243676.
(en)Akbar M, Abel R, Seyler TM, Gerner HJ, Möhring K (2007). „Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.”. BJU Int. 100 (3): 639–45. DOI:10.1111/j.1464-410X.2007.06977.x. PMID 17532858.

bcm.edu

(en)Dr Ramsey Markus, Botox for Wrinkles Baylor College of Medicine Dermatology

botoxguide.org

(en)Side Effects Botox - all you need to know about Botox Arhivirano 2014-04-19 na Wayback Machine-u

doi.org

dx.doi.org

(en) Montecucco C, Molgó J (2005). „Botulinal neurotoxins: revival of an old killer”. Current opinion in pharmacology 5 (3): 274–279. DOI:10.1016/j.coph.2004.12.006. PMID 15907915.
(en) Arnon, Stephen S.; Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K; Working Group on Civilian Biodefense. (2001-02-21). „Botulinum Toxin as a Biological Weapon: Medical and Public Health Management” (PDF, 0.5 MB). Journal of the American Medical Association 285 (8): 1059–1070. DOI:10.1001/jama.285.8.1059. PMID 11209178.
(en) Frank J. Erbguth (2004). „Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin”. Movement Disorders (John Wiley & Sons on behalf of the Movement Disorder Society) 19 (S8): S2–S6. DOI:10.1002/mds.20003. PMID 15027048.
(de) Émile van Ermengem, E.P. (February 1897). „Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus” (German). Zeitschrift für Hygiene und Infektionskrankheiten 26 (1): 1–56. DOI:10.1007/BF02220526. PMID 399378.
(en)Naumann M, So Y, Argoff CE, et al. (May 2008). „Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology”. Neurology 70 (19): 1707–14. DOI:10.1212/01.wnl.0000311390.87642.d8. PMID 18458231.
(en)Schurch B, Corcos J (2005). „Botulinum toxin injections for paediatric incontinence”. Current opinion in urology 15 (4): 264–7. DOI:10.1097/01.mou.0000172401.92761.86. PMID 15928517.
(en)Duthie J, Wilson D, Herbison G, Wilson D (2007). „Botulinum toxin injections for adults with overactive bladder syndrome.”. Cochrane database of systematic reviews (Online) 3 (3): CD005493. DOI:10.1002/14651858.CD005493.pub2. PMID 17636801.
(en)Akbar M, Abel R, Seyler TM, Gerner HJ, Möhring K (2007). „Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.”. BJU Int. 100 (3): 639–45. DOI:10.1111/j.1464-410X.2007.06977.x. PMID 17532858.
(en)Coskun H, Duran Y, Dilege E, Mihmanli M, Seymen H, Demirkol MO (2005). „Effect on gastric emptying and weight reduction of botulinum toxin-A injection into the gastric antral layer: an experimental study in the obese rat model”. Obesity surgery : the official journal of the American Society for Bariatric Surgery and of the Obesity Surgery Society of Australia and New Zealand 15 (8): 1137–43. DOI:10.1381/0960892055002275. PMID 16197786.
(en) Clark RP, Berris CE. (August 1989). „Botulinum Toxin: A treatment for facial asymmetry caused by facial nerve paralysis.”. Plastic and Reconstructive Surgery 84 (2): 353–355. DOI:10.1097/01.prs.0000205566.47797.8d. ISSN 0032-1052. PMID 2748749.
(en) Carruthers JD, Carruthers JA. (January 1992). „Treatment of Glabellar Frown Lines with C. Botulinum-A Exotoxin”. The Journal of Dermatologic Surgery and Oncology 18 (1): 17–21. DOI:10.1111/j.1524-4725.1992.tb03295.x. PMID 1740562.
(en)Coté TR, Mohan AK, Polder JA, Walton MK, Braun MM (September 2005). „Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases”. J. Am. Acad. Dermatol. 53 (3): 407–15. DOI:10.1016/j.jaad.2005.06.011. PMID 16112345.

emedicinehealth.com

(en)BOTOX® Injections-Risks [WebMD], Pristupljeno 4. oktobar 2010

fda.gov

(en) „Botulinum Toxin Type A Product Approval Information - Licensing Action 4/12/02”. Food and Drug Administration. Page last updated 29 October 2009. Pristupljeno 26. jul 2010.

jstor.org

(en) Snipe, P. Tessmer & Sommer, H. (August 1928). „Studies on Botulinus Toxin: 3. Acid Precipitation of Botulinus Toxin”. The Journal of Infectious Diseases (University of Chicago Press) 43 (2): 152–160. ISSN 0022-1899.

mef.hr

hubpp.mef.hr

(sh)Hrvatska udruga bolesnika s poremećajem pokreta - DISTONIJA Arhivirano 2010-10-17 na Wayback Machine-u, Pristupljeno 3. oktobar 2010

nationalledger.com

(en) Warren, Leslie (May 2010). „Kim Kardashian Botox Reveal - Kendra Wilkinson Tape Tops Kim”. National Ledger. Pristupljeno 26. jul 2010. ^{[mrtav link]}

neurology.org

(en)Naumann M, So Y, Argoff CE, et al. (May 2008). „Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology”. Neurology 70 (19): 1707–14. DOI:10.1212/01.wnl.0000311390.87642.d8. PMID 18458231.

neurologyindia.com

(en)Panicker JN, Muthane UB (2003). „Botulinum toxins: pharmacology and its current therapeutic evidence for use”. Neurology India 51 (4): 455–60. PMID 14742921.

nih.gov

ncbi.nlm.nih.gov

Schiavo, G., Rossetto, O., Catsicas, S., Polverino De Laureto, P., DasGupta, B.R., Benfenati, F. and Montecucco, C. (1993). „Identification of the nerve-terminal targets of botulinum neurotoxins serotypes A, D and E”. J. Biol. Chem. 268: 23784-23787. PMID 8226912.
Schiavo, G., Santucci, A., DasGupta, B.R., Mehta, P.P., Jontes, J., Benfenati, F., Wilson, M.C. and Montecucco, C. (1993). „Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds”. FEBS Lett. 335: 99-103. PMID 8243676.
Schiavo, G., Shone, C.C., Rossetto, O., Alexander, F.C.G. and Montecucco, C. (1993). „Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin”. J. Biol. Chem. 268: 11516-11519. PMID 8505288.
Schiavo, G., Malizio, C., Trimble, W.S., Polverino De Laureto, P., Milan, G., Sugiyama, H., Johnson, E.A. and Montecucco, C. (1994). „Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond”. J. Biol. Chem. 269: 20213-20216. PMID 8051110.
Montecucco, C. and Schiavo, G. (1994). „Mechanism of action of tetanus and botulinum neurotoxins”. Mol. Microbiol. 8: 1-13. PMID 7527117.
Schiavo, G. and Montecucco, C. (1995). „Tetanus and botulism neurotoxins”. Methods Enzymol. 248: 643-652. PMID 7674951.
(en) Montecucco C, Molgó J (2005). „Botulinal neurotoxins: revival of an old killer”. Current opinion in pharmacology 5 (3): 274–279. DOI:10.1016/j.coph.2004.12.006. PMID 15907915.
(en) Arnon, Stephen S.; Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K; Working Group on Civilian Biodefense. (2001-02-21). „Botulinum Toxin as a Biological Weapon: Medical and Public Health Management” (PDF, 0.5 MB). Journal of the American Medical Association 285 (8): 1059–1070. DOI:10.1001/jama.285.8.1059. PMID 11209178.
(en) Frank J. Erbguth (2004). „Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin”. Movement Disorders (John Wiley & Sons on behalf of the Movement Disorder Society) 19 (S8): S2–S6. DOI:10.1002/mds.20003. PMID 15027048.
(de) Émile van Ermengem, E.P. (February 1897). „Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus” (German). Zeitschrift für Hygiene und Infektionskrankheiten 26 (1): 1–56. DOI:10.1007/BF02220526. PMID 399378.
(en)Panicker JN, Muthane UB (2003). „Botulinum toxins: pharmacology and its current therapeutic evidence for use”. Neurology India 51 (4): 455–60. PMID 14742921.
(en)Naumann M, So Y, Argoff CE, et al. (May 2008). „Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology”. Neurology 70 (19): 1707–14. DOI:10.1212/01.wnl.0000311390.87642.d8. PMID 18458231.
(en)Schurch B, Corcos J (2005). „Botulinum toxin injections for paediatric incontinence”. Current opinion in urology 15 (4): 264–7. DOI:10.1097/01.mou.0000172401.92761.86. PMID 15928517.
(en)Duthie J, Wilson D, Herbison G, Wilson D (2007). „Botulinum toxin injections for adults with overactive bladder syndrome.”. Cochrane database of systematic reviews (Online) 3 (3): CD005493. DOI:10.1002/14651858.CD005493.pub2. PMID 17636801.
(en)Akbar M, Abel R, Seyler TM, Gerner HJ, Möhring K (2007). „Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.”. BJU Int. 100 (3): 639–45. DOI:10.1111/j.1464-410X.2007.06977.x. PMID 17532858.
(en)Trzciński R, Dziki A, Tchórzewski M (2002). „Injections of botulinum A toxin for the treatment of anal fissures”. The European journal of surgery = Acta chirurgica 168 (12): 720–3. PMID 15362583.
(en)Coskun H, Duran Y, Dilege E, Mihmanli M, Seymen H, Demirkol MO (2005). „Effect on gastric emptying and weight reduction of botulinum toxin-A injection into the gastric antral layer: an experimental study in the obese rat model”. Obesity surgery : the official journal of the American Society for Bariatric Surgery and of the Obesity Surgery Society of Australia and New Zealand 15 (8): 1137–43. DOI:10.1381/0960892055002275. PMID 16197786.
(en) Clark RP, Berris CE. (August 1989). „Botulinum Toxin: A treatment for facial asymmetry caused by facial nerve paralysis.”. Plastic and Reconstructive Surgery 84 (2): 353–355. DOI:10.1097/01.prs.0000205566.47797.8d. ISSN 0032-1052. PMID 2748749.
(en) Carruthers JD, Carruthers JA. (January 1992). „Treatment of Glabellar Frown Lines with C. Botulinum-A Exotoxin”. The Journal of Dermatologic Surgery and Oncology 18 (1): 17–21. DOI:10.1111/j.1524-4725.1992.tb03295.x. PMID 1740562.
(en)Koenraad De Boulle, Steven Fagien, Boris Sommer, and Richard Glogau, Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction, Clin Interv Aging. 2010; 5: 101–118. Published online 2010 April 26.PMC2861845 [pubmed]
(en)Coté TR, Mohan AK, Polder JA, Walton MK, Braun MM (September 2005). „Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases”. J. Am. Acad. Dermatol. 53 (3): 407–15. DOI:10.1016/j.jaad.2005.06.011. PMID 16112345.

plasticsurgery.org

(en)American Society of Plastic Surgeons Website Arhivirano 2010-10-24 na Wayback Machine-u, Pristupljeno 4. oktobar 2010.

uni-duesseldorf.de

(de)Definition und Therapie der primären Hyperhidrose; Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG); 02/2007; ES1

web.archive.org

(en)American Society of Plastic Surgeons Website Arhivirano 2010-10-24 na Wayback Machine-u, Pristupljeno 4. oktobar 2010.
(sh)Hrvatska udruga bolesnika s poremećajem pokreta - DISTONIJA Arhivirano 2010-10-17 na Wayback Machine-u, Pristupljeno 3. oktobar 2010
(en)Side Effects Botox - all you need to know about Botox Arhivirano 2014-04-19 na Wayback Machine-u

worldcat.org

(en) Snipe, P. Tessmer & Sommer, H. (August 1928). „Studies on Botulinus Toxin: 3. Acid Precipitation of Botulinus Toxin”. The Journal of Infectious Diseases (University of Chicago Press) 43 (2): 152–160. ISSN 0022-1899.
(en) Clark RP, Berris CE. (August 1989). „Botulinum Toxin: A treatment for facial asymmetry caused by facial nerve paralysis.”. Plastic and Reconstructive Surgery 84 (2): 353–355. DOI:10.1097/01.prs.0000205566.47797.8d. ISSN 0032-1052. PMID 2748749.